News

Artis News

All Cell & Gene Therapy DNA Syngoi GMP Grant ARPA-H

Landmark Bio Forges New Collaboration to Accelerate Early-Stage Translational Cell and Gene Therapies

Press Release · May 02, 2026

Agreement establishes framework for advancing Mass General Brigham-originated cell and gene therapies

Landmark Bio to support early-stage development and manufacturing through...

DNA Syngoi GMP

Press Release

May 02, 2026

SAN DIEGO & BOSTON & BILBAO, Spain--(BUSINESS WIRE)--Artis BioSolutions (“Artis”), a San Diego-based advanced-therapies...

DNA Syngoi GMP

Press Release

May 02, 2026

WATERTOWN, Mass.--(BUSINESS WIRE)--Landmark Bio, an Artis BioSolutions company dedicated to accelerating the translation of...

Grant ARPA-H

Press Release

May 01, 2026

WATERTOWN, Mass.--(BUSINESS WIRE)--Landmark Bio, an Artis BioSolutions company dedicated to accelerating the translation of...